BEVERLY GARDNER: Open Payments
NPI 1629089065 · CROSSVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$579 in 36 payments from 11 companies in 2025. Trend: 2023 $502 · 2024 $399 · 2025 $579
Food & beverage: $579
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 13 | $192 |
| Corcept Therapeutics | 10 | $173 |
| Novo Nordisk Inc | 2 | $52 |
| ABBVIE INC. | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 2 | $14 |
Products named: Korlym, TRELEGY ELLIPTA, Ozempic, VRAYLAR, SHINGRIX, Auvelity, PAXLOVID, JARDIANCE.
Industry payments across TN — which companies pay providers there.
